scPharmaceuticals Inc.
SCPH
$4.85
$0.286.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 36.50% | -3.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 36.50% | -3.28% | |||
| Cost of Revenue | 44.37% | -12.46% | |||
| Gross Profit | 33.20% | 1.17% | |||
| SG&A Expenses | -0.85% | 0.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.80% | 3.57% | |||
| Operating Income | 19.50% | -8.65% | |||
| Income Before Tax | 8.70% | -4.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.70% | -4.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.70% | -4.76% | |||
| EBIT | 19.50% | -8.65% | |||
| EBITDA | 19.51% | -8.65% | |||
| EPS Basic | 8.78% | -4.34% | |||
| Normalized Basic EPS | 10.15% | -6.67% | |||
| EPS Diluted | 8.78% | -4.34% | |||
| Normalized Diluted EPS | 10.15% | -6.67% | |||
| Average Basic Shares Outstanding | 0.08% | 0.40% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||